• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Research progress on proteasome subunits in regulating occurrence and development of hepatocellular carcinoma.蛋白酶体亚基在调控肝细胞癌发生发展中的研究进展。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Jun 25;50(3):396-402. doi: 10.3724/zdxbyxb-2021-0146.
2
Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.Notch1信号通路通过抑制Akt/Hdm2介导的p53降解并上调p53依赖性DR5表达,使人类肝癌细胞对肿瘤坏死因子相关凋亡诱导配体诱导的凋亡敏感。
J Biol Chem. 2009 Jun 12;284(24):16183-16190. doi: 10.1074/jbc.M109.002105. Epub 2009 Apr 17.
3
Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy.PSMB5 蛋白和哺乳动物蛋白酶体 β 亚基受组成型激活的信号转导和转录激活因子 3 (STAT3)的调节:在硼替佐米介导的抗癌治疗中的潜在作用。
J Biol Chem. 2014 May 2;289(18):12612-22. doi: 10.1074/jbc.M113.542829. Epub 2014 Mar 13.
4
LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway.LBH589 通过抑制 Gankyrin/STAT3/Akt 通路抑制肝癌的增殖和转移。
Mol Cancer. 2013 Oct 5;12(1):114. doi: 10.1186/1476-4598-12-114.
5
Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.Rpn10 通过 PTEN/Akt 信号通路调节缺氧诱导因子 1α促进肝癌的进展。
Cancer Lett. 2019 Apr 10;447:1-11. doi: 10.1016/j.canlet.2019.01.020. Epub 2019 Jan 20.
6
Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.拳参提取物通过抑制信号转导子和转录激活子 3 信号通路发挥抗肝癌作用。
J Ethnopharmacol. 2019 Mar 25;232:62-72. doi: 10.1016/j.jep.2018.12.019. Epub 2018 Dec 13.
7
Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.膳食黄烷酮 α-倒捻子素通过稳定 SHP1 抑制 STAT3 信号通路抑制肝癌的抗癌活性。
Cell Death Dis. 2020 Jan 24;11(1):63. doi: 10.1038/s41419-020-2227-4.
8
In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.microRNA-221 通过靶向 SOCS3 对 JAK-STAT3 信号通路的影响在肝癌发展和进展中的体内和体外研究。
J Cell Physiol. 2019 Apr;234(4):3500-3514. doi: 10.1002/jcp.26863. Epub 2018 Oct 28.
9
Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.氯化两面针碱通过抑制 JAK1/STAT3 信号通路抑制肝癌细胞体内生长。
Int J Mol Med. 2013 Jul;32(1):79-84. doi: 10.3892/ijmm.2013.1358. Epub 2013 Apr 22.
10
NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating the proteasome-dependent degradation of ISGylated p53.NFE2L3 通过调节泛素化 p53 的蛋白酶体依赖降解来驱动肝细胞癌细胞增殖。
Cancer Sci. 2023 Sep;114(9):3523-3536. doi: 10.1111/cas.15887. Epub 2023 Jun 22.

本文引用的文献

1
PSMC2 Regulates Cell Cycle Progression Through the p21/Cyclin D1 Pathway and Predicts a Poor Prognosis in Human Hepatocellular Carcinoma.PSMC2通过p21/细胞周期蛋白D1途径调控细胞周期进程,并预测人类肝细胞癌的不良预后。
Front Oncol. 2021 Feb 26;11:607021. doi: 10.3389/fonc.2021.607021. eCollection 2021.
2
Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling.双亚苄基哌啶酮 RA190 通过结合 RPN13 和抑制 NF-κB 信号通路治疗肝细胞癌。
BMC Cancer. 2020 May 6;20(1):386. doi: 10.1186/s12885-020-06896-0.
3
The proteasome 19S cap and its ubiquitin receptors provide a versatile recognition platform for substrates.蛋白酶体 19S 帽及其泛素受体为底物提供了一个多功能的识别平台。
Nat Commun. 2020 Jan 24;11(1):477. doi: 10.1038/s41467-019-13906-8.
4
Identification of proteasome subunit alpha type-1 as a novel biomarker in HBV-associated hepatocellular carcinoma tissue interstitial fluid by proteomic analysis.通过蛋白质组学分析鉴定蛋白酶体α-1型亚基作为HBV相关肝细胞癌组织间质液中的一种新型生物标志物。
Int J Clin Exp Pathol. 2017 Jul 1;10(7):7812-7820. eCollection 2017.
5
PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism.PSMD1 和 PSMD2 通过调节细胞脂滴代谢调控 HepG2 细胞增殖和凋亡。
BMC Mol Biol. 2019 Nov 8;20(1):24. doi: 10.1186/s12867-019-0141-z.
6
Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.去泛素化酶 PSMD14 通过稳定 GRB2 增强肝癌的生长和转移。
Cancer Lett. 2020 Jan 28;469:22-34. doi: 10.1016/j.canlet.2019.10.025. Epub 2019 Oct 18.
7
is Up-regulated in Pancreatic Cancer and Promotes Cancer Cell Proliferation and Inhibits Apoptosis.在胰腺癌中上调并促进癌细胞增殖且抑制细胞凋亡。
J Cancer. 2019 Aug 27;10(20):4939-4946. doi: 10.7150/jca.27616. eCollection 2019.
8
The Oncoprotein Gankyrin/PSMD10 as a Target of Cancer Therapy.癌蛋白 Gankyrin/PSMD10 作为癌症治疗的靶点。
Adv Exp Med Biol. 2019;1164:63-71. doi: 10.1007/978-3-030-22254-3_5.
9
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma.来那度胺-地塞米松联合伊沙佐米诱导治疗后序贯伊沙佐米维持治疗复发/难治性多发性骨髓瘤患者的研究
Br J Cancer. 2019 Oct;121(9):751-757. doi: 10.1038/s41416-019-0581-8. Epub 2019 Sep 27.
10
Proteasome subunit α1 overexpression preferentially drives canonical proteasome biogenesis and enhances stress tolerance in yeast.蛋白酶体亚基α1 过表达优先驱动经典蛋白酶体生物发生并增强酵母的应激耐受性。
Sci Rep. 2019 Aug 27;9(1):12418. doi: 10.1038/s41598-019-48889-5.

蛋白酶体亚基在调控肝细胞癌发生发展中的研究进展。

Research progress on proteasome subunits in regulating occurrence and development of hepatocellular carcinoma.

机构信息

Institute of Immunology.

出版信息

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Jun 25;50(3):396-402. doi: 10.3724/zdxbyxb-2021-0146.

DOI:10.3724/zdxbyxb-2021-0146
PMID:34402263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8710273/
Abstract

Proteasome is the eukaryotic organelle responsible for degradation of short-lived proteins and involved in maintaining cellular protein homeostasis. It has been reported that during the occurrence and development of hepatocellular carcinoma (HCC), the regulatory particle subunits of proteasome regulate a series of tumor-related proteins, and proliferation, survival-associated signaling molecules, including PTEN gene, P53, Bcl-2, Bcl-2 interacting mediator of cell death (Bim), cyclin-dependent kinase 4(CDK4), transforming growth factor β receptor (TGFBR), E2F1, growth factor receptor-bound protein 2 (GRB2) . Meanwhile, these subunits regulate some tumor-associated pathway protein, such as signal transducer and activator of transcription 3 (STAT3) and protein kinase B (AKT), inducing their malfunction to promote the occurrence, proliferation, invasion and metastasis of HCC. The core particle subunits are more to perform the degradation of HCC-related proteins, so inhibitors targeting the core particle show a good anti-tumor effect. This review summarizes the current research progress on the regulation and mechanism of proteasome subunits in promoting the occurrence and development .

摘要

蛋白酶体是负责降解短寿命蛋白质的真核细胞器,参与维持细胞蛋白质的内稳态。据报道,在肝细胞癌(HCC)的发生和发展过程中,蛋白酶体的调节颗粒亚基调节一系列与肿瘤相关的蛋白质,包括 PTEN 基因、P53、Bcl-2、Bcl-2 相互作用的细胞死亡介体(Bim)、细胞周期蛋白依赖性激酶 4(CDK4)、转化生长因子β受体(TGFBR)、E2F1、生长因子受体结合蛋白 2(GRB2)。同时,这些亚基调节一些与肿瘤相关的通路蛋白,如信号转导和转录激活因子 3(STAT3)和蛋白激酶 B(AKT),导致它们功能失调,从而促进 HCC 的发生、增殖、侵袭和转移。核心颗粒亚基更能执行 HCC 相关蛋白的降解,因此针对核心颗粒的抑制剂表现出良好的抗肿瘤作用。本文综述了蛋白酶体亚基在促进 HCC 发生和发展中的调节作用及其机制的研究进展。